Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 16.03B | 14.80B | 14.20B | 11.74B | 10.79B |
Gross Profit | 16.03B | 6.40B | 2.06B | 1.64B | 1.39B |
EBITDA | 3.15B | 2.68B | 2.88B | 2.12B | 1.94B |
Net Income | 1.66B | 1.31B | 1.22B | 1.03B | 576.00M |
Balance Sheet | |||||
Total Assets | 39.85B | 36.72B | 35.90B | 32.85B | 30.16B |
Cash, Cash Equivalents and Short-Term Investments | 3.82B | 4.25B | 4.62B | 3.66B | 3.70B |
Total Debt | 5.17B | 5.54B | 6.17B | 5.72B | 6.65B |
Total Liabilities | 28.82B | 26.97B | 26.30B | 24.29B | 23.00B |
Stockholders Equity | 11.06B | 9.79B | 9.63B | 8.59B | 7.18B |
Cash Flow | |||||
Free Cash Flow | 2.06B | 1.87B | 2.20B | 1.57B | 2.69B |
Operating Cash Flow | 2.30B | 2.05B | 2.40B | 1.71B | 2.85B |
Investing Cash Flow | -1.12B | -348.00M | -752.00M | -419.00M | -319.00M |
Financing Cash Flow | -2.01B | -1.75B | -980.00M | -1.58B | -1.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $15.09B | 11.18 | 33.96% | 3.60% | 5.21% | -3.74% | |
77 Outperform | $22.92B | 12.34 | 16.96% | 4.71% | 10.50% | 17.48% | |
75 Outperform | $1.41B | 10.19 | 12.79% | ― | -0.40% | 36.44% | |
74 Outperform | $3.58B | 90.96 | 5.82% | ― | 5.52% | ― | |
73 Outperform | $9.79B | 22.63 | 11.70% | 4.95% | -5.16% | -56.06% | |
66 Neutral | $5.70B | 11.53 | 11.24% | 9.02% | -1.89% | 90.72% | |
60 Neutral | $44.05B | 4.50 | -12.81% | 4.08% | 1.86% | -43.08% |